MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway

MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway

Show other versions (1)

Chikungunya virus (CHIKV) epidemics around the world have created public health concern with the unavailability of effective drugs and vaccines. This emphasizes the need for molecular understanding of host-virus interactions for developing effective targeted antivirals. Microarray analysis was carri...

Full description

Saved in:
Bibliographic Details
Main Authors: Prabhudutta Mamidi, Tapas Kumar Nayak, Abhishek Kumar, Sameer Kumar, Sanchari Chatterjee, Saikat De, Ankita Datey, Soumyajit Ghosh, Supriya Suman Keshry, Sharad Singh, Eshna Laha, Amrita Ray, Subhasis Chattopadhyay, Soma Chattopadhyay
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2021
Subjects:
Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Online Access:https://doaj.org/article/fbfa341d712c4abd9c6213d86efad4e1
Tags: Add Tag
No Tags, Be the first to tag this record!
Search Result 1
MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway.
Get full text
article
Save to List
Saved in:
Show all versions (2)

Similar Items